ABSTRACT
Objective: This study investigates the impact of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and aspirin on endometrial receptivity and clinical pregnancy outcomes in individuals with a history of recurrent abortions. Methods: In this retrospective study, 131 individuals with recurrent abortions treated at our facility from July 2019 to December 2020 were split into two groups: mixed therapy and control. The mixed therapy group received aspirin and rhG-CSF, while the control group had no specific treatment. Primary endpoint: live birth rate; secondary: pregnancy rate at 20 weeks. We also evaluated abortion rates, newborn weight, pre-eclampsia, premature delivery, fetal/newborn congenital malformations, and maternal drug adverse reactions. Additionally, we analyzed endometrial blood flow three weeks post-treatment. Results: The analysis encompassed 131 individuals, with 65 in the control group and 66 in the mixed therapy group. Notably, the mixed therapy group (n = 54) exhibited a markedly higher live birth rate than the control group (P < .05). In terms of medication-related side effects, the control group showed no adverse reactions, while the mixed therapy group reported mild effects (skin itching in three cases, leukocytosis in seven, and bone pain in one case) that did not significantly impact outcomes. Pre-treatment, the mixed therapy group had a notably lower resistive index, pulsatility index, and systolic-to-diastolic ratio compared to the control group, with statistical significance (P < .05). The control group's indices remained unchanged (P > .05). Conclusions: In women with a history of recurrent abortions, the administration of recombinant human granulocyte colony-stimulating factor and aspirin can effectively and safely improve live birth rates. This improvement may be associated with enhanced endometrial receptivity.
Subject(s)
Abortion, Habitual , Pregnancy Outcome , Pregnancy , Infant, Newborn , Humans , Female , Retrospective Studies , Aspirin/therapeutic use , Abortion, Habitual/drug therapy , Abortion, Habitual/prevention & control , Granulocyte Colony-Stimulating Factor/therapeutic useABSTRACT
OBJECTIVE: To minimize the adverse events of uterine compression suture in controlling postpartum hemorrhage (PPH) and to search for a prophylactic approach to potential PPH. METHODS: A retrospective analysis was performed in 39 women with removable retropubic uterine compression suture (RRUCS) to stop PPH due to uterine atony during cesarean section (CS). The procedure was to suspend and compress the uterus to the retropubic abdominal wall using an absorbable suture. RESULTS: The technique was sufficient to stanch bleeding immediately in 36 patients (92.31%, 36/39). No morbidity or abnormalities occurred in women who underwent RRUCS. Subsequent pregnancies occurred in 10 cases, but the others lacked the desire for future pregnancy. CONCLUSION: RRUCS is a simple, safe, and effective technique in controlling atonic PPH; it is also used as a prophylactic application in patients with potential PPH after CS.
Subject(s)
Cesarean Section , Postpartum Hemorrhage , Uterine Inertia , Cesarean Section/adverse effects , Female , Humans , Postpartum Hemorrhage/prevention & control , Postpartum Hemorrhage/surgery , Pregnancy , Retrospective Studies , Suture Techniques , Sutures , Uterine Inertia/surgery , Uterus/surgeryABSTRACT
AIM: To avoid complications associated with uterine compression sutures, we devised a ring compression suture (RCS). METHODS: The RCS was performed on 12 patients with post-partum hemorrhage (PPH) during cesarean section. The suture was inserted 0.5 cm below the attachment point of the uterosacral ligament into the uterine cavity and pushed downward through the cervical canal into the vagina. The other end of the stitch was threaded through the lower abdominal wall, from the inside of the abdomen cavity to the outside of the abdominal wall, emerging at the external surface of the lower abdomen 2 cm lateral to the ventral median line and 1 cm above the symphysis pubis. Then, the two ends of the suture (the end in the vagina had been pulled out in advance) were tied tightly on the pudendum. The same stitch was repeated on the contralateral side. After 48 h postoperatively, the suture was removed through the vagina under sterilization. RESULTS: All 12 women with PPH who underwent RCS achieved hemostasis, and complications related to RCS were not seen. Two of them had successful pregnancies postoperatively. The remaining women had no desire for a further pregnancy. CONCLUSION: The procedure can be used as an alternative to peripartum hysterectomy and also as a prophylactic application in PPH.
Subject(s)
Cesarean Section/methods , Outcome Assessment, Health Care , Postpartum Hemorrhage/surgery , Suture Techniques , Adult , Cesarean Section/adverse effects , Humans , Postpartum Hemorrhage/etiology , Young AdultSubject(s)
Postpartum Hemorrhage , Uterine Inertia , Female , Humans , Myometrium/surgery , Placenta , Postpartum Hemorrhage/surgery , Pregnancy , Serous Membrane , SuturesABSTRACT
OBJECTIVE: To observe the efficacy and safety of a uterine folding hemostatic technique in controlling atonic postpartum hemorrhage (PPH) during cesarean delivery. METHODS: Thirty-nine women with severe postpartum bleeding from uterine inertia, which did not react to conventional initial management protocols, underwent a uterine folding hemostasis. The procedure was to fold the uterine fundus onto the anterior wall of the corpus uterus using an absorbable suture that thread tautly through the inner myometrial layer of the uterus 1-3 cm below the fundus (not entered into uterine cavity) and 1-2 cm above and below the CS incision (entered into uterine cavity 2-4 cm medal to bilateral border of the uterus). RESULTS: The technique was sufficient to stanch bleeding immediately in 32 patients (82.1 %). Seven women underwent hypogastric arteries ligation (1 case) or uterine arterial embolization (6 cases) because of continuous bleeding after the procedure. There were no morbidities or abnormalities of the uterus in these 32 patients. Eight women had pregnancies after this hemostasis and the others lacked the desire for future pregnancy. CONCLUSION: Uterine folding hemostasis is a simple, safe and effective technique to control the atonic PPH.
Subject(s)
Hemostasis, Surgical/methods , Postpartum Hemorrhage/surgery , Uterine Inertia/surgery , Uterus/surgery , Adult , Cesarean Section/adverse effects , Embolization, Therapeutic/methods , Female , Hemostasis , Humans , Postpartum Hemorrhage/etiology , Pregnancy , Suture Techniques/adverse effects , Sutures , Young AdultSubject(s)
Postpartum Hemorrhage/prevention & control , Suture Techniques , Uterus/surgery , Female , Humans , Pregnancy , SuturesSubject(s)
Cesarean Section , Postpartum Hemorrhage , Female , Humans , Postpartum Period , Pregnancy , SuturesSubject(s)
Organ Sparing Treatments , Postpartum Hemorrhage/prevention & control , Suture Techniques , Uterine Inertia/surgery , Uterus/surgery , Adult , China , Female , Hospitals, General , Humans , Organ Sparing Treatments/adverse effects , Postpartum Hemorrhage/etiology , Pregnancy , Suture Techniques/adverse effects , Uterine Inertia/physiopathology , Uterus/physiopathologySubject(s)
Sutures , Uterine Inertia/surgery , Humans , Postpartum Hemorrhage/surgery , Suture Techniques , Uterus/surgerySubject(s)
Early Detection of Cancer/methods , Mass Screening/methods , Papillomavirus Infections/diagnosis , Uterine Cervical Dysplasia/prevention & control , Uterine Cervical Neoplasms/prevention & control , Female , Humans , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/virology , Vaginal Smears , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/virologySubject(s)
Abdominal Wall , Laparoscopy , Uterine Prolapse , Female , Humans , Abdominal Wall/surgery , Uterus/surgery , Uterine Prolapse/surgery , Treatment Outcome , Surgical MeshSubject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Evidence-Based Medicine , Neoplasms, Glandular and Epithelial/drug therapy , Ovarian Neoplasms/drug therapy , Carboplatin/administration & dosage , Carcinoma, Ovarian Epithelial , Cisplatin/administration & dosage , Drug Administration Routes , Female , Humans , Neoadjuvant Therapy , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/pathology , Paclitaxel/administration & dosageSubject(s)
Placenta Accreta , Pregnancy , Female , Humans , Placenta Accreta/surgery , Ligation , Cesarean Section , Sutures , Arteries , Retrospective StudiesABSTRACT
OBJECTIVE: To evaluate the effectiveness and safety of uterine arterial embolization (UAE) in the management of symptomatic uterine myomas compared with myomectomy. METHODS: All clinical trials on UAE treating symptomatic uterine myomas indexed in PubMed and Chinese National Knowledge Infrastructure (CNKI) were reviewed using meta-analysis by Revman 4.1 software. The patients were classified into two groups, i.e., UAE trial group and control group. Intervention method in control group was surgery of uterine myomectomy. There were no differences between two groups in age, general physical status, and manifestation of uterine myoma. RESULTS: Six hundred and eighty patients with symptomatic uterine myoma in eight trials were included into this study according to selection criteria of Cochrane collaboration. Meta-analysis indicated that weight of every trial contributing to the study was related to its number of patients in direct ratio, but not related to quality scale of the trial. There were no statistical differences between these trials in evaluation criteria (P > 0.05). Relative risk (RR) between UAE patients and control group was 0.95, and 95% CI was 0.92 - 0.99. The success rate (92.3%) of UAE group was 95% of control group (96.7%), with a significant difference between them (P < 0.05). CONCLUSIONS: Surgical procedures to treat uterine myomas have more effective outcomes than UAE. Patients who select UAE procedure may have 95% opportunity to improve clinical symptoms and avoid some surgical risks, and also have a higher life quality in future, although this has to be testified by long term follow-up.